The Neuronal Synuclein Disease Integrated Staging System ‐– Opportunities to advance Lewy body dementia research
Kathleen L. Poston · 2025
Read The Neuronal Synuclein Disease Integrated Staging System ‐– Opportunities to advance Lewy body dementia research by Kathleen L. Poston (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11712574.txt.
Description
Kathleen Poston explains a new staging system that defines Parkinson's disease and Lewy body dementia by biology rather than symptoms. New tests can now find the clumped protein behind both conditions in living patients. Under the proposal, the shared condition is called Neuronal Synuclein Disease. It is staged by two anchors — the protein's presence and damage to dopamine neurons — plus how much daily function is impaired.
Early stages cover people with the protein but no symptoms, or faint signs only. Later stages add growing impairment. Poston argues the scheme will sharpen drug trials by enrolling biologically uniform patients, and will let researchers mix patients who first showed movement or thinking problems.
Catalog record
| CREATOR | Kathleen L. Poston |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |